Ohr Pharmaceutical Inc. Product Pipeline Review 2015

Research Beam added a report “Ohr Pharmaceutical, Inc. Product Pipeline Review 2015”

Global Markets Directs, Ohr Pharmaceutical, Inc. Product Pipeline Review 2015, provides an overview of the Ohr Pharmaceutical, Inc. s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ohr Pharmaceutical, Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Enquiry @ http://www.researchbeam.com/ohr-pharmaceutical-inc-product-pipeline-review-2015-market/enquire-about-report

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Ohr Pharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Ohr Pharmaceutical, Inc. s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Ohr Pharmaceutical, Inc. s pipeline products

Reasons to buy

Evaluate Ohr Pharmaceutical, Inc. s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Ohr Pharmaceutical, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Ohr Pharmaceutical, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Ohr Pharmaceutical, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ohr Pharmaceutical, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

Explore the dormant and discontinued projects of Ohr Pharmaceutical, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ohr Pharmaceutical Inc. Snapshot 5
Ohr Pharmaceutical Inc. Overview 5
Key Information 5
Key Facts 5
Ohr Pharmaceutical Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Ohr Pharmaceutical Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Ohr Pharmaceutical Inc. - Pipeline Products Glance 10
Ohr Pharmaceutical Inc. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Ohr Pharmaceutical Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Ohr Pharmaceutical Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Ohr Pharmaceutical Inc. - Drug Profiles 13
squalamine lactate 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Drugs for Allergic Conjunctivitis 16
Product Description 16
Mechanism of Action 16
R&D Progress 16

Source: http://www.researchbeam.com/ohr-pharmaceutical-inc-product-pipeline-review-2015-market

About Us:

We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities.

In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

Contact Us:

Deep Joshi

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

U.S. & Canada Toll Free: + 1-800-910-6452

International: + 1-503-894-6022

UK: + 44-845-528-1300

India: +91 20 66346070

Fax : +1 (855) 550-5975

Email: help@researchbeam.com/

Web: http://www.researchbeam.com/

Blog: http://www.researchbeam.blogspot.in/